DE69701298D1 - Hydroxypyridin-Derivate, ihre Herstellung und ihre pharmazeutische Verwendung - Google Patents

Hydroxypyridin-Derivate, ihre Herstellung und ihre pharmazeutische Verwendung

Info

Publication number
DE69701298D1
DE69701298D1 DE69701298T DE69701298T DE69701298D1 DE 69701298 D1 DE69701298 D1 DE 69701298D1 DE 69701298 T DE69701298 T DE 69701298T DE 69701298 T DE69701298 T DE 69701298T DE 69701298 D1 DE69701298 D1 DE 69701298D1
Authority
DE
Germany
Prior art keywords
group
substituted
alkyl group
halogen
hydrogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69701298T
Other languages
English (en)
Other versions
DE69701298T2 (de
Inventor
Mitsuru Shiraishi
Tsuyoshi Maekawa
Toshifumi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE69701298D1 publication Critical patent/DE69701298D1/de
Publication of DE69701298T2 publication Critical patent/DE69701298T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE69701298T 1996-04-15 1997-04-14 Hydroxypyridin-Derivate, ihre Herstellung und ihre pharmazeutische Verwendung Expired - Fee Related DE69701298T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9290496 1996-04-15

Publications (2)

Publication Number Publication Date
DE69701298D1 true DE69701298D1 (de) 2000-03-23
DE69701298T2 DE69701298T2 (de) 2000-10-05

Family

ID=14067477

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69701298T Expired - Fee Related DE69701298T2 (de) 1996-04-15 1997-04-14 Hydroxypyridin-Derivate, ihre Herstellung und ihre pharmazeutische Verwendung

Country Status (5)

Country Link
US (1) US5891895A (de)
EP (1) EP0802187B1 (de)
AT (1) ATE189814T1 (de)
CA (1) CA2202578A1 (de)
DE (1) DE69701298T2 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7329670B1 (en) 1997-12-22 2008-02-12 Bayer Pharmaceuticals Corporation Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
US20080300281A1 (en) * 1997-12-22 2008-12-04 Jacques Dumas Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
US20080269265A1 (en) * 1998-12-22 2008-10-30 Scott Miller Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
US7928239B2 (en) 1999-01-13 2011-04-19 Bayer Healthcare Llc Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
EP1158985B1 (de) 1999-01-13 2011-12-28 Bayer HealthCare LLC GAMMA CARBOXYARYLSUBSTITUIERTE DIPHENYLHARNSTOFFVERBINDUNGEN ALS p38 KINASEHEMMER
EP1140840B1 (de) * 1999-01-13 2006-03-22 Bayer Pharmaceuticals Corp. -g(v)-carboxyaryl substituierte diphenyl harnstoffe als raf kinase inhibitoren
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
RU2319693C9 (ru) 1999-01-13 2008-08-20 Байер Копэрейшн Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
US7235576B1 (en) 2001-01-12 2007-06-26 Bayer Pharmaceuticals Corporation Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
US7371763B2 (en) * 2001-04-20 2008-05-13 Bayer Pharmaceuticals Corporation Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
EP1769795B1 (de) * 2001-12-03 2013-07-24 Bayer HealthCare LLC Arylharnstoffverbindungen in Kombination mit anderen zytostatischen oder zytotoxischen Substanzen zur Behandlung von Krebs beim Menschen
WO2003068229A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
WO2003068223A1 (en) * 2002-02-11 2003-08-21 Bayer Corporation Aryl ureas with raf kinase and angiogenesis inhibiting activity
AU2003209118A1 (en) * 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Aryl ureas as kinase inhibitors
EP1478358B1 (de) 2002-02-11 2013-07-03 Bayer HealthCare LLC Sorafenib Tosylate zur Behandlung von durch unnormale Angiogenese gekennzeichneten Krankheiten
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
CA2526636C (en) 2003-05-20 2012-10-02 Bayer Pharmaceuticals Corporation Diaryl ureas for diseases mediated by pdgfr
JP2009513485A (ja) * 2003-06-26 2009-04-02 ノバルティス アクチエンゲゼルシャフト ある種の抗菌性ｎ−ホルミルヒドロキシルアミン化合物の製造に有用な中間体の製造法
CL2004001834A1 (es) * 2003-07-23 2005-06-03 Bayer Pharmaceuticals Corp Compuesto 4-{4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenoxi}-piridin-2-metilamida, inhibidor de la raf, vegfr, p38 y pdgfr quinasas, sus sales; composiicon farmaceutica; combinacion farmaceutica; y su uso para tratar trastornos hiperprol
MXPA06012394A (es) * 2004-04-30 2007-01-31 Bayer Pharmaceuticals Corp Derivados de pirazolilurea sustituidos utiles en el tratamiento de cancer.
AU2006210641A1 (en) 2005-02-01 2006-08-10 Icagen, Inc. Imines as ion channel modulators

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH350461A (de) * 1957-12-06 1960-11-30 Ciba Geigy Verwendung von Oxyketonen zum Schutze gegen ultraviolette Strahlung
JPS49119718A (de) * 1973-03-23 1974-11-15
CH609980A5 (en) * 1974-08-30 1979-03-30 Ciba Geigy Ag Process for the preparation of novel piperidine derivatives
US4297359A (en) * 1978-07-25 1981-10-27 Acf Chemiefarma Nv Anti-ulcer compositions containing certain pyridyl oxime ethers
US4798841A (en) * 1987-03-31 1989-01-17 Warner-Lambert Company Tetrahydropyridine oxime cholinergic agents and method of treatment
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer
JP2765876B2 (ja) * 1988-10-24 1998-06-18 科研製薬株式会社 ピリジルケトオキシムエーテル誘導体
EP0388682A1 (de) * 1989-03-15 1990-09-26 Bayer Ag Substituierte Heteroarylphenylether, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide
FR2644456B1 (fr) * 1989-03-17 1991-07-05 Rhone Poulenc Sante Nouveaux derives du 1h, 3h-pyrrolo(1,2-c)thiazolecarboxamide-7, leur preparation et les compositions pharmaceutiques qui les contiennent
JPH0499767A (ja) * 1990-08-20 1992-03-31 Nippon Bayeragrochem Kk ３―ベンゾイルピリジン０―ベンジルオキシム類の除草剤としての利用
EP0983992B1 (de) * 1992-04-22 2005-10-26 Ligand Pharmaceuticals Incorporated Verbindungen mit Retinoid x rezeptorselektivität
TW266206B (de) * 1993-04-28 1995-12-21 Takeda Pharm Industry Co Ltd
JPH08175994A (ja) * 1994-10-27 1996-07-09 Takeda Chem Ind Ltd 脂質代謝改善剤

Also Published As

Publication number Publication date
ATE189814T1 (de) 2000-03-15
US5891895A (en) 1999-04-06
DE69701298T2 (de) 2000-10-05
EP0802187B1 (de) 2000-02-16
CA2202578A1 (en) 1997-10-15
EP0802187A1 (de) 1997-10-22

Similar Documents

Publication Publication Date Title
DE69701298D1 (de) Hydroxypyridin-Derivate, ihre Herstellung und ihre pharmazeutische Verwendung
ATE180468T1 (de) Anthranilsäure derivate
EP1035123A4 (de) Neue heterozyklische verbindungen
ATE228133T1 (de) Fungizide trifluorophenyltriazolopyrimidine
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
DE3782883D1 (de) Pyridincarboxamid-derivate und ihre verwendung als fungizides mittel.
ATE74132T1 (de) Imid-derivate, ihre herstellung und ihre verwendung.
ATE199253T1 (de) Antidepressiv wirkende 3-halophenylpiperazinyl- propylderivate von substituierten triazolonen und triazoldionen
DE3767778D1 (de) Entzuendung verhindernde und allergie heilende mittel.
ATE92489T1 (de) Imid-derivate, ihre herstellung und verwendung.
FI844333L (fi) 11-substituerade 5h,11h-pyrrolo/2,1-c/ /1,4/benzoxazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
ATE260252T1 (de) Thiocolchicin-derivate mit entzündungshemmender und muskelrelaxierender wirkung
DK0436348T3 (da) Pyridylcyklopropanderivater med fungicid aktivitet
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
FI941963A (fi) Pyridiinijohdannaiset, niiden valmistus ja käyttö
MX9202994A (es) Derivados de 2-aminoacetamida.
DE69428206D1 (de) Chinolincarbonsäurederivate und ihre salze
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
TR200001941T1 (tr) TNF ve PDE-IV önleyici aktiviteye sahip heterosiklik bileşiklerin N-oksitleri.
ATE218138T1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
DE69008130D1 (de) Glutarsäurederivate und ihre Herstellung.
DE69914563D1 (de) Azaindol derivate und ihre Verwendung als antithrombotische Wirkstoffe
ES2058182T3 (es) Analogos de mitomicina. un procedimiento para su preparacion y composiciones farmaceuticas.
DE60324734D1 (de) Calixaren-Derivate mit antiviraler Wirkung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee